The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Allograft Demineralized Bone Matrix Market Research Report 2025
Synopsis
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix.
The global Allograft Demineralized Bone Matrix market was valued at US$ 623 million in 2023 and is anticipated to reach US$ 913.9 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for Allograft Demineralized Bone Matrix is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Allograft Demineralized Bone Matrix is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Allograft Demineralized Bone Matrix include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group and Hans Biomed, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Allograft Demineralized Bone Matrix, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allograft Demineralized Bone Matrix.
Report Scope
The Allograft Demineralized Bone Matrix market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allograft Demineralized Bone Matrix market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allograft Demineralized Bone Matrix manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Segment by Type
Gel
Putty
Putty with Chips
Others
Segment by Application
Dental
Spine Surgery
Trauma Surgery
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Allograft Demineralized Bone Matrix manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Allograft Demineralized Bone Matrix in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix.
The global Allograft Demineralized Bone Matrix market was valued at US$ 623 million in 2023 and is anticipated to reach US$ 913.9 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for Allograft Demineralized Bone Matrix is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Allograft Demineralized Bone Matrix is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Allograft Demineralized Bone Matrix include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group and Hans Biomed, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Allograft Demineralized Bone Matrix, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allograft Demineralized Bone Matrix.
Report Scope
The Allograft Demineralized Bone Matrix market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allograft Demineralized Bone Matrix market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allograft Demineralized Bone Matrix manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Segment by Type
Gel
Putty
Putty with Chips
Others
Segment by Application
Dental
Spine Surgery
Trauma Surgery
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Allograft Demineralized Bone Matrix manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Allograft Demineralized Bone Matrix in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Allograft Demineralized Bone Matrix Market Overview
1.1 Product Overview and Scope of Allograft Demineralized Bone Matrix
1.2 Allograft Demineralized Bone Matrix Segment by Type
1.2.1 Global Allograft Demineralized Bone Matrix Market Value Comparison by Type (2024-2030)
1.2.2 Gel
1.2.3 Putty
1.2.4 Putty with Chips
1.2.5 Others
1.3 Allograft Demineralized Bone Matrix Segment by Application
1.3.1 Global Allograft Demineralized Bone Matrix Market Value by Application: (2024-2030)
1.3.2 Dental
1.3.3 Spine Surgery
1.3.4 Trauma Surgery
1.4 Global Allograft Demineralized Bone Matrix Market Size Estimates and Forecasts
1.4.1 Global Allograft Demineralized Bone Matrix Revenue 2019-2030
1.4.2 Global Allograft Demineralized Bone Matrix Sales 2019-2030
1.4.3 Global Allograft Demineralized Bone Matrix Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Allograft Demineralized Bone Matrix Market Competition by Manufacturers
2.1 Global Allograft Demineralized Bone Matrix Sales Market Share by Manufacturers (2019-2024)
2.2 Global Allograft Demineralized Bone Matrix Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Allograft Demineralized Bone Matrix Average Price by Manufacturers (2019-2024)
2.4 Global Allograft Demineralized Bone Matrix Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Allograft Demineralized Bone Matrix, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Allograft Demineralized Bone Matrix, Product Type & Application
2.7 Allograft Demineralized Bone Matrix Market Competitive Situation and Trends
2.7.1 Allograft Demineralized Bone Matrix Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Allograft Demineralized Bone Matrix Players Market Share by Revenue
2.7.3 Global Allograft Demineralized Bone Matrix Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Allograft Demineralized Bone Matrix Retrospective Market Scenario by Region
3.1 Global Allograft Demineralized Bone Matrix Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Allograft Demineralized Bone Matrix Global Allograft Demineralized Bone Matrix Sales by Region: 2019-2030
3.2.1 Global Allograft Demineralized Bone Matrix Sales by Region: 2019-2024
3.2.2 Global Allograft Demineralized Bone Matrix Sales by Region: 2025-2030
3.3 Global Allograft Demineralized Bone Matrix Global Allograft Demineralized Bone Matrix Revenue by Region: 2019-2030
3.3.1 Global Allograft Demineralized Bone Matrix Revenue by Region: 2019-2024
3.3.2 Global Allograft Demineralized Bone Matrix Revenue by Region: 2025-2030
3.4 North America Allograft Demineralized Bone Matrix Market Facts & Figures by Country
3.4.1 North America Allograft Demineralized Bone Matrix Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Allograft Demineralized Bone Matrix Sales by Country (2019-2030)
3.4.3 North America Allograft Demineralized Bone Matrix Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Allograft Demineralized Bone Matrix Market Facts & Figures by Country
3.5.1 Europe Allograft Demineralized Bone Matrix Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Allograft Demineralized Bone Matrix Sales by Country (2019-2030)
3.5.3 Europe Allograft Demineralized Bone Matrix Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Allograft Demineralized Bone Matrix Market Facts & Figures by Country
3.6.1 Asia Pacific Allograft Demineralized Bone Matrix Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Allograft Demineralized Bone Matrix Sales by Country (2019-2030)
3.6.3 Asia Pacific Allograft Demineralized Bone Matrix Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Allograft Demineralized Bone Matrix Market Facts & Figures by Country
3.7.1 Latin America Allograft Demineralized Bone Matrix Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Allograft Demineralized Bone Matrix Sales by Country (2019-2030)
3.7.3 Latin America Allograft Demineralized Bone Matrix Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Allograft Demineralized Bone Matrix Market Facts & Figures by Country
3.8.1 Middle East and Africa Allograft Demineralized Bone Matrix Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Allograft Demineralized Bone Matrix Sales by Country (2019-2030)
3.8.3 Middle East and Africa Allograft Demineralized Bone Matrix Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Allograft Demineralized Bone Matrix Sales by Type (2019-2030)
4.1.1 Global Allograft Demineralized Bone Matrix Sales by Type (2019-2024)
4.1.2 Global Allograft Demineralized Bone Matrix Sales by Type (2025-2030)
4.1.3 Global Allograft Demineralized Bone Matrix Sales Market Share by Type (2019-2030)
4.2 Global Allograft Demineralized Bone Matrix Revenue by Type (2019-2030)
4.2.1 Global Allograft Demineralized Bone Matrix Revenue by Type (2019-2024)
4.2.2 Global Allograft Demineralized Bone Matrix Revenue by Type (2025-2030)
4.2.3 Global Allograft Demineralized Bone Matrix Revenue Market Share by Type (2019-2030)
4.3 Global Allograft Demineralized Bone Matrix Price by Type (2019-2030)
5 Segment by Application
5.1 Global Allograft Demineralized Bone Matrix Sales by Application (2019-2030)
5.1.1 Global Allograft Demineralized Bone Matrix Sales by Application (2019-2024)
5.1.2 Global Allograft Demineralized Bone Matrix Sales by Application (2025-2030)
5.1.3 Global Allograft Demineralized Bone Matrix Sales Market Share by Application (2019-2030)
5.2 Global Allograft Demineralized Bone Matrix Revenue by Application (2019-2030)
5.2.1 Global Allograft Demineralized Bone Matrix Revenue by Application (2019-2024)
5.2.2 Global Allograft Demineralized Bone Matrix Revenue by Application (2025-2030)
5.2.3 Global Allograft Demineralized Bone Matrix Revenue Market Share by Application (2019-2030)
5.3 Global Allograft Demineralized Bone Matrix Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Allograft Demineralized Bone Matrix Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 J &J (DePuy Synthes)
6.2.1 J &J (DePuy Synthes) Corporation Information
6.2.2 J &J (DePuy Synthes) Description and Business Overview
6.2.3 J &J (DePuy Synthes) Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2019-2024)
6.2.4 J &J (DePuy Synthes) Allograft Demineralized Bone Matrix Product Portfolio
6.2.5 J &J (DePuy Synthes) Recent Developments/Updates
6.3 SeaSpine
6.3.1 SeaSpine Corporation Information
6.3.2 SeaSpine Description and Business Overview
6.3.3 SeaSpine Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SeaSpine Allograft Demineralized Bone Matrix Product Portfolio
6.3.5 SeaSpine Recent Developments/Updates
6.4 Xtant Medical
6.4.1 Xtant Medical Corporation Information
6.4.2 Xtant Medical Description and Business Overview
6.4.3 Xtant Medical Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Xtant Medical Allograft Demineralized Bone Matrix Product Portfolio
6.4.5 Xtant Medical Recent Developments/Updates
6.5 Zimmer Biomet
6.5.1 Zimmer Biomet Corporation Information
6.5.2 Zimmer Biomet Description and Business Overview
6.5.3 Zimmer Biomet Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zimmer Biomet Allograft Demineralized Bone Matrix Product Portfolio
6.5.5 Zimmer Biomet Recent Developments/Updates
6.6 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Stryker Allograft Demineralized Bone Matrix Product Portfolio
6.6.5 Stryker Recent Developments/Updates
6.7 Straumann
6.6.1 Straumann Corporation Information
6.6.2 Straumann Description and Business Overview
6.6.3 Straumann Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Straumann Allograft Demineralized Bone Matrix Product Portfolio
6.7.5 Straumann Recent Developments/Updates
6.8 Wright Medical Group
6.8.1 Wright Medical Group Corporation Information
6.8.2 Wright Medical Group Description and Business Overview
6.8.3 Wright Medical Group Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Wright Medical Group Allograft Demineralized Bone Matrix Product Portfolio
6.8.5 Wright Medical Group Recent Developments/Updates
6.9 Hans Biomed
6.9.1 Hans Biomed Corporation Information
6.9.2 Hans Biomed Description and Business Overview
6.9.3 Hans Biomed Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hans Biomed Allograft Demineralized Bone Matrix Product Portfolio
6.9.5 Hans Biomed Recent Developments/Updates
6.10 Arthrex
6.10.1 Arthrex Corporation Information
6.10.2 Arthrex Description and Business Overview
6.10.3 Arthrex Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Arthrex Allograft Demineralized Bone Matrix Product Portfolio
6.10.5 Arthrex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Allograft Demineralized Bone Matrix Industry Chain Analysis
7.2 Allograft Demineralized Bone Matrix Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Allograft Demineralized Bone Matrix Production Mode & Process
7.4 Allograft Demineralized Bone Matrix Sales and Marketing
7.4.1 Allograft Demineralized Bone Matrix Sales Channels
7.4.2 Allograft Demineralized Bone Matrix Distributors
7.5 Allograft Demineralized Bone Matrix Customers
8 Allograft Demineralized Bone Matrix Market Dynamics
8.1 Allograft Demineralized Bone Matrix Industry Trends
8.2 Allograft Demineralized Bone Matrix Market Drivers
8.3 Allograft Demineralized Bone Matrix Market Challenges
8.4 Allograft Demineralized Bone Matrix Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
